Weight-loss drugmakers Novo Nordisk and Eli Lilly are more likely to turn into laggards in 2024 than other stock market stars of this year, according to Bloomberg’s Markets Live Pulse survey.
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
Here's why they picked Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Axsome Therapeutics): One promising growth stock that investors may be overlooking today is Axsome Therapeutics. With a market capitalization of around $3.2 billion, this is still a fairly small biotech stock for investors to load up on before it gets much bigger.